A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer.
Kunitoh H, Akiyama Y, Kusaba H, Yamamoto N, Sekine I, Ohe Y, Kubota K, Tamura T, Shinkai T, Kodama T, Goto K, Niho S, Nishiwaki Y, Saijo N.
Kunitoh H, et al.
Lung Cancer. 2001 Aug-Sep;33(2-3):259-65. doi: 10.1016/s0169-5002(01)00189-1.
Lung Cancer. 2001.
PMID: 11551421
Clinical Trial.